Maternal autoimmunity and adverse pregnancy outcomes

Journal of Autoimmunity

Volumn 50, Issue , 2014, Pages 83-86

  Gleicher, Norbert ^a,b  

^a CENTER FOR HUMAN REPRODUCTION   (United States)

^b Foundation for Reproductive Medicine   (United States)

Author keywords

Autoimmunity; Hyperthyroidism; Hypothyroidism; Preeclampsia eclampsia; Premature labor; Thyroid disease

Indexed keywords

ADVERSE OUTCOME; AUTOIMMUNITY; COHORT ANALYSIS; ECLAMPSIA; EDITORIAL; HUMAN; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; ADULT; COMPLICATION; FEMALE; FETUS; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PATHOLOGY; PREGNANCY; UNITED STATES;

ADULT; AUTOIMMUNITY; FEMALE; FETUS; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE TOLERANCE; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84899066877     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.12.009     Document Type: Editorial

References (54)

1. Sen A., Kushnir V.A., Barad D.H., Gleicher N. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol 2013.
2. Camacho E.M., Verstappen S.M., Lunt M., Bunn D.K., Symmons D.P. Multiple adverse pregnancy outcomes before symptom onset are associated with a worse disease outcome in women with recent-onset inflammatory polyarthritis. Ann Rheum Dis 2012, 71:528-533.
3. Dolhain R.J. Rheumatoid arthritis and pregnancy; not only for rheumatologists interested in female health issues. Ann Rheum Dis 2010, 69:317-318.
4. Sangle S.R., Lutalo P.M., Davies R.J., Khamashta M.A., D'Cruz D.P. B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. J Autoimmun 2013, 43:55-59.
5. Blank M., Krause I., Dotan N., Anafi L., Eisenstein M., Cervera R., et al. Anti-GalNAcbeta: a novel anti-glycan autoantibody associated with pregnancy loss in women with antiphospholipid syndrome and in a mouse experimental model. J Autoimmun 2012, 39:420-427.
6. Amador-Patarroyo M.J., Arbelaez J.G., Mantilla R.D., Rodriguez-Rodriguez A., Cardenas-Roldan J., Pineda-Tamayo R., et al. Sjogren's syndrome at the crossroad of polyautoimmunity. J Autoimmun 2012, 39:199-205.
7. Bakalov V.K., Gutin L., Cheng C.M., Zhou J., Sheth P., Shah K., et al. Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun 2012, 38:315-321.
8. Lin H.C., Chen S.F., Lin H.C., Chen Y.H. Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis 2010, 69:715-717.
9. Carp H.J., Selmi C., Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J Autoimmun 2012, 38:J266-J274.
10. Michael D.L., Cohn E., Aslam A., Buyon J.P., Salmon J.E. Sex ratios among children of lupus pregnancies. Arthritis Rheum 2013, 65:282.
11. Noel N., Wechsler B., Nizard J., Costedoat-Chalumeau N., Boutin du L.T., Dommergues M., et al. Behcet's disease and pregnancy. Arthritis Rheum 2013, 65:2450-2456.
12. Andreoli L., Tincani A. Beyond the "syndrome": antiphospholipid antibodies as risk factors. Arthritis Rheum 2012, 64:342-345.
13. Gleicher N., Weghofer A., Barad D.H. Cutting edge assessment of the impact of autoimmunity on female reproductive success. J Autoimmun 2012, 38:J74-J80.
14. Munoz-Suano A., Kallikourdis M., Sarris M., Betz A.G. Regulatory T cells protect from autoimmune arthritis during pregnancy. J Autoimmun 2012, 38:J103-J108.
15. de Man Y.A., Bakker-Jonges L.E., Goorbergh C.M., Tillemans S.P., Hooijkaas H., Hazes J.M., et al. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis 2010, 69:420-423.
16. de la Torre Y.M., Pregnolato F., D'Amelio F., Grossi C., Di Simone N., Pasqualini F., et al. Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the beta2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. J Autoimmun 2012, 38:J209-J215.
17. Jorgensen K.T., Pedersen B.V., Jacobsen S., Biggar R.J., Frisch M. National cohort study of reproductive risk factors for rheumatoid arthritis in Denmark: a role for hyperemesis, gestational hypertension and pre-eclampsia?. Ann Rheum Dis 2010, 69:358-363.
18. Andreoli L., Fredi M., Nalli C., Reggia R., Lojacono A., Motta M., et al. Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. J Autoimmun 2012, 38:J197-J208.
19. Wallenius M., Skomsvoll J.F., Irgens L.M., Salvesen K.A., Koldingsnes W., Mikkelsen K., et al. Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis 2010, 69:332-336.
20. Jorgensen K.T., Nielsen N.M., Pedersen B.V., Jacobsen S., Frisch M. Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort. J Autoimmun 2012, 38:J120-J128.
21. Westbrook R.H., Yeoman A.D., Kriese S., Heneghan M.A. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 2012, 38:J239-J244.
22. Salliot C., Bombardier C., Saraux A., Combe B., Dougados M. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort. Ann Rheum Dis 2010, 69:1683-1686.
23. Jorgensen K.T., Pedersen B.V., Nielsen N.M., Jacobsen S., Frisch M. Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmun 2012, 38:J81-J87.
24. Twig G., Shina A., Amital H., Shoenfeld Y. Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. J Autoimmun 2012, 38:J275-J281.
25. Wallenius M., Skomsvoll J.F., Irgens L.M., Salvesen K.A., Nordvag B.Y., Koldingsnes W., et al. Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum 2011, 63:1534-1542.
26. Otomo K., Atsumi T., Amengual O., Fujieda Y., Kato M., Oku K., et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum 2012, 64:504-512.
27. Quintero O.L., Amador-Patarroyo M.J., Montoya-Ortiz G., Rojas-Villarraga A., Anaya J.M. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012, 38:J109-J119.
28. Spinillo A., Beneventi F., Ramoni V., Caporali R., Locatelli E., Simonetta M., et al. Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy. Ann Rheum Dis 2012, 71:918-923.
29. Männistö T., Mendola P., Reddy U., Laughon S.K. Thyroid disease and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab 2013, 98:2725-2733.
30. Stagnaro-Green A. Optimal care of the pregnant woman with thyroid disease. J Clin Endocrinol Metab 2012, 97:2619-2622.
31. Chen J.S., Ford J.B., Roberts C.L., Simpson J.M., March L.M. Pregnancy outcomes in women with juvenile idiopathic arthritis: a population-based study. Rheumatology (Oxford) 2013, 52:1119-1125.
32. Evers I.M., de Valk H.W., Visser G.H. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004, 328:915.
33. Holmes V.A., Young I.S., Patterson C.C., Pearson D.W., Walker J.D., Maresh M.J., et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care 2011, 34:1683-1688.
34. Liu J., Zhao Y., Song Y., Zhang W., Bian X., Yang J., et al. Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women. J Matern Fetal Neonatal Med 2012, 25:261-266.
35. Gleicher N. Does the immune system induce labor? Lessons from preterm deliveries in women with autoimmune diseases. Clin Rev Allergy Immunol 2010, 39:194-206.
36. Wahren-Herlenius M., Dörner T. Autoimmune rheumatic diseases 3. Immunopathogenic mechanisms of systemic autoimmune diseases. Lancet 2013, 382:819.
37. Salustiano E.M., De Pinho J.C., Provost K., Ruano R., Zugaib M. Maternal serum hormonal factors in the pathogenesis of preeclampsia. Obstet Gynecol Surv 2013, 68:141-150.
38. Cemgil Arikan D., Aral M., Coskun A., Ozer A. Plasma IL-4, IL-8, IL-12, interferon-gamma and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. J Matern Fetal Neonatal Med 2012, 25:1569-1573.
39. Norman J.E., Shennan A.H. Prevention of preterm birth - why can't we do any better?. Lancet 2013, 381:184-185.
40. Pawelec M., Palczynski B., Krzemieniewska J., Karmowski M., Korys J., Latkowski K., et al. Initiation of preterm labor. Adv Clin Exp Med 2013, 22:283-288.
41. Voltolini C., Torricelli M., Conti N., Vellucci F.L., Severi F.M., Petraglia F. Understanding spontaneous preterm birth: from underlying mechanisms to predictive and preventive interventions. Reprod Sci 2013, 20:1274-1292.
42. Pinheiro M.B., Martins-Filho O.A., Mota A.P., Alpoim P.N., Godoi L.C., Silveira A.C., et al. Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. Cytokine 2013, 62:165-173.
43. Jawaheer D., Zhu J.L., Nohr E.A., Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 2011, 63:1517-1521.
44. Sjöberg L., Pitkäniemi J., Haapala L., Kaaja R., Tuomilehto J. Fertility in people with childhood-onset type 1 diabetes. Diabetologia 2013, 56:78-81.
45. Gleicher N. Reproductive failure prior to the onset of clinical autoimmune disease. Rheumatology (Oxford) 1999, 38:485-487.
46. Bansal A.S. Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol 2010, 64:307-315.
47. Bansal A.S., Bajardeen B., Shehata H., Thum M.Y. Recurrent miscarriages and autoimmunity. Expert Rev Clin Immunol 2011, 7:37-44.
48. Gleicher N., Barad D.H. Gestational dermatosis shortly after implantation associated with parental class II HLA compatibility and maternal immune activation: preliminary report of prospective case series. Dermatology 2011, 222:206-211.
49. Starzl T.E. Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res 2007, 38:6-41.
50. Gleicher N. Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature. Am J Obstet Gynecol 2007, 196(5):e1-e7.
51. Hahn S., Holzgreve W. Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia. Hum Reprod Update 2002, 8:501-508.
52. Scott J.S. Immunological diseases and pregnancy. Br Med J 1966, 1:1559-1567.
53. Kim S.H., Shim S.H., Sung S.R., Lee K.A., Shim J.Y., Cha D.H., et al. Gene expression analysis of the microdissected trophoblast layer of human placenta after the spontaneous onset of labor. PLoS One 2013, 8:e77648.
54. Korevaar T.I., Schalekamp-Timmerman S., de Rijke Y.B., Visser W.E., Visser W., De Muinck Keizer-Schrama S.M.P.F., et al. Hypothyroxemia and TPO antibody positivity are risk factors for premature delivery: the Generayion R Study. J Clin Endocrinol Metab 2013, 98:4382-4390.